|
March
2008 Off
the Wire . . .
|
| Date
|
Title
|
| 03-03-08
|
Merck
Serono Launches New Formulation Of Interferon Beta-1a
|
| 03-04-08
|
Multiple
Sclerosis: Prognosis Better Than Expected
|
| 03-05-08
|
New
SSDI Guidebook Available To Individuals With Mutiple Sclerosis
|
| 03-06-08
|
Sirtris Pharmaceuticals' SRT501
Slows Retinal Ganglion Cell Loss During Optic Neuritis In A Preclinical
Model Of Multiple Sclerosis
|
| 03-06-08
|
Chickenpox
Virus in CSF is associated with MS relapses
|
| 03-07-08
|
Another
twist on stem cells
|
| 03-07-08
|
MS
Society Criticises Producers Of The Bill Over Made-up Drug, UK
|
| 03-07-08
|
Pixantrone
To Be Studied In Phase I/II Trial For Aggressive Multiple Sclerosis
|
| 03-07-08
|
Evidence
that Copaxone is neuroprotective
|
| 03-11-08
|
Transient
5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing
pathologies in autoimmune optic neuritis into two distinct pathology
profiles.
|
| 03-11-08
|
The
CB2 cannabinoid receptor controls myeloid progenitor trafficking.
Involvement in the pathogenesis of an animal model of multiple
sclerosis.
|
| 03-11-08
|
The
influence of positive experiences on depression and quality of life in
persons with multiple sclerosis.
|
| 03-11-08
|
[Subcutaneous
interferon-beta-1a in the treatment of multiple sclerosis.]
|
| 03-11-08
|
Take
Action: Help Move Research Forward
|
| 03-11-08
|
MS
Trial Alert - Large Study of Oral Laqunimod Seeking Participants
|
| 03-12-08
|
Teva
Pharmaceutical's Altered Peptide Ligand Copaxone Boasts The Greatest
Patient Share Among First And Second Line Therapies For Multiple
Sclerosis
|
| 03-12-08
|
Accelerated
Cure Project 2007 Annual Report Available
|
| 03-13-08
|
Richard
Cohen's latest book “Strong at the Broken Places,”
|
| 03-13-08
|
Endless
Pools, Inc. And National Multiple Sclerosis Society Raise Awareness For
Healthy Living
|
| 03-13-08
|
Eye
drug looked at in MS
|
| 03-13-08
|
Petition:
Prevent Discrimination Against Workers with Disabilities
|
| 03-13-08
|
What
Will You Do? Join The Movement To End Multiple Sclerosis During MS
Awareness Week March 10-17
|
| 03-13-08
|
Opexa
Therapeutics Announces Completion Of Mid Study Descriptive Analysis On
Phase IIb Trial Of Tovaxin(R) For Treatment Of Multiple Sclerosis
|
| 03-14-08
|
Mouse
Nerve Cells Protected From Damage By New Drug
|
| 03-19-08
|
Peptimmune
Completes Phase I Study With A Novel Peptide Copolymer For The
Treatment Of Multiple Sclerosis
|
| 03-21-08
|
New
Tool To Study The Link Between Body Temperature And Severity Of MS
Symptoms
|
| 03-21-08
|
Endless
Pools Inc & National Multiple Sclerosis Society Fight Back
Against MS - Unique Swimming Pools Promote Rehabilitation Through
Aquatic Therapy
|
| 03-24-08
|
Gene-Environment
Interactions Study Looks For Links To Motor Neuron Disease
|
| 03-24-08
|
EMEA
Concludes New Advice To Doctors And Patients For Tysabri (natalizumab)
Needed, Europe
|
| 03-25-08
|
BTG
Initiates Clinical Study of Novel Multiple Sclerosis Treatment
|
| 03-25-08
|
Fox’s
Janice Dean Reveals MS Diagnosis
|
| 03-26-08
|
Article
about PatientsLikeMe in NY Times
|
| 03-27-08
|
Pixantrone
To Be Studied In Phase I/II Trial For Aggressive MS
|
| 03-27-08
|
Loss
Of Mobility Found To Impact Quality Of Life And Emotional And Financial
Health Of Most People Living With Multiple Sclerosis
|
| 03-28-08
|
MS
in focus
|
| 03-28-08
|
Various
Forms Of Hope Among Patients With Amyotrophic Lateral Sclerosis
|
| 03-28-08
|
Some
With MS Put Their Hopes in a Diet
|
| 03-31-08
|
Multiple
Sclerosis Therapy Has Potential New Target
|
| 03-31-08
|
Descriptive Analysis on Phase IIb Trial of Tovaxin for Treatment of MS
|
